FDA tells JNJ to throw out 60 million doses of COVID vaccine made at troubled plant
Sanofi's treatment for rare anemia hits 2nd endpoint in phase 3
DOJ investigation remains even after an internal probe at Lilly plant found the company didn't mislead FDA
Ocugen plans to seek full FDA approval for Covaxin vaccine
*please scroll down for all the latest news*